Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Buchdunger

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
American Journal of Respiratory and Critical Care Medicine|October 6, 1999
Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the ratE A Kallio, P K Koskinen, E Aavik, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitorsB Kasper, S Fruehauf, B Schiedlmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine classE Buchdunger, J Zimmermann, H Mett, et al.
Transplantation Proceedings|March 27, 2001
PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbitsK Lemström, R Sihvola, J Tikkanen, et al.
Cancer Research|January 1, 1996
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivativeE Buchdunger, J Zimmermann, H Mett, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-SrcM Missbach, E Altmann, L Widler, et al.
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
Cancer Research|April 18, 2001
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumorsK Pietras, A Ostman, M Sjöquist, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptorsE Buchdunger, C L Cioffi, N Law, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Respiratory and Critical Care Medicine|October 6, 1999
Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the ratE A Kallio, P K Koskinen, E Aavik, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitorsB Kasper, S Fruehauf, B Schiedlmeier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine classE Buchdunger, J Zimmermann, H Mett, et al.
Transplantation Proceedings|March 27, 2001
PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbitsK Lemström, R Sihvola, J Tikkanen, et al.
Cancer Research|January 1, 1996
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivativeE Buchdunger, J Zimmermann, H Mett, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-SrcM Missbach, E Altmann, L Widler, et al.
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
Cancer Research|April 18, 2001
Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumorsK Pietras, A Ostman, M Sjöquist, et al.
Pharmacology & Therapeutics|August 24, 1999
Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agentD Fabbro, E Buchdunger, J Wood, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptorsE Buchdunger, C L Cioffi, N Law, et al.
Pageof 5